These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29769266)

  • 1. Regulation of BDNF Release by ARMS/Kidins220 through Modulation of Synaptotagmin-IV Levels.
    López-Benito S; Sánchez-Sánchez J; Brito V; Calvo L; Lisa S; Torres-Valle M; Palko ME; Vicente-García C; Fernández-Fernández S; Bolaños JP; Ginés S; Tessarollo L; Arévalo JC
    J Neurosci; 2018 Jun; 38(23):5415-5428. PubMed ID: 29769266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of Kidins220 isoforms in Huntington's disease.
    Sebastián-Serrano Á; Simón-García A; Belmonte-Alfaro A; Pose-Utrilla J; Santos-Galindo M; Del Puerto A; García-Guerra L; Hernández IH; Schiavo G; Campanero MR; Lucas JJ; Iglesias T
    Brain Pathol; 2020 Jan; 30(1):120-136. PubMed ID: 31264746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARMS/Kidins220 regulates nociception by controlling brain-derived neurotrophic factor secretion.
    Sánchez-Sánchez J; Vicente-García C; Cañada-García D; Martín-Zanca D; Arévalo JC
    Pain; 2023 Mar; 164(3):563-576. PubMed ID: 35916735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant Huntingtin Impairs BDNF Release from Astrocytes by Disrupting Conversion of Rab3a-GTP into Rab3a-GDP.
    Hong Y; Zhao T; Li XJ; Li S
    J Neurosci; 2016 Aug; 36(34):8790-801. PubMed ID: 27559163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
    Ma Q; Yang J; Li T; Milner TA; Hempstead BL
    Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity-dependent BDNF release via endocytic pathways is regulated by synaptotagmin-6 and complexin.
    Wong YH; Lee CM; Xie W; Cui B; Poo MM
    Proc Natl Acad Sci U S A; 2015 Aug; 112(32):E4475-84. PubMed ID: 26216953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain.
    Ginés S; Bosch M; Marco S; Gavaldà N; Díaz-Hernández M; Lucas JJ; Canals JM; Alberch J
    Eur J Neurosci; 2006 Feb; 23(3):649-58. PubMed ID: 16487146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ankyrin Repeat-rich Membrane Spanning/Kidins220 protein regulates dendritic branching and spine stability in vivo.
    Wu SH; Arévalo JC; Sarti F; Tessarollo L; Gan WB; Chao MV
    Dev Neurobiol; 2009 Aug; 69(9):547-57. PubMed ID: 19449316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice.
    Zajac MS; Pang TY; Wong N; Weinrich B; Leang LS; Craig JM; Saffery R; Hannan AJ
    Hippocampus; 2010 May; 20(5):621-36. PubMed ID: 19499586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of BDNF and Full-Length TrkB Receptor Ameliorate Striatal Neural Survival in Huntington's Disease.
    Silva A; Naia L; Dominguez A; Ribeiro M; Rodrigues J; Vieira OV; Lessmann V; Rego AC
    Neurodegener Dis; 2015; 15(4):207-18. PubMed ID: 25896770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease.
    Zuccato C; Marullo M; Conforti P; MacDonald ME; Tartari M; Cattaneo E
    Brain Pathol; 2008 Apr; 18(2):225-38. PubMed ID: 18093249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ankyrin repeat-rich membrane spanning (ARMS)/Kidins220 scaffold protein is regulated by activity-dependent calpain proteolysis and modulates synaptic plasticity.
    Wu SH; Arévalo JC; Neubrand VE; Zhang H; Arancio O; Chao MV
    J Biol Chem; 2010 Dec; 285(52):40472-8. PubMed ID: 20943655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Kidins220/ARMS Splice Isoforms: Potential Specific Regulators of Neuronal and Cardiovascular Development.
    Schmieg N; Thomas C; Yabe A; Lynch DS; Iglesias T; Chakravarty P; Schiavo G
    PLoS One; 2015; 10(6):e0129944. PubMed ID: 26083449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BH3-only proteins Bid and Bim(EL) are differentially involved in neuronal dysfunction in mouse models of Huntington's disease.
    García-Martínez JM; Pérez-Navarro E; Xifró X; Canals JM; Díaz-Hernández M; Trioulier Y; Brouillet E; Lucas JJ; Alberch J
    J Neurosci Res; 2007 Sep; 85(12):2756-69. PubMed ID: 17387706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of brain-derived neurotrophic factor in Huntington's disease.
    Zuccato C; Cattaneo E
    Prog Neurobiol; 2007 Apr; 81(5-6):294-330. PubMed ID: 17379385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARMS/Kidins220 and synembryn-B levels regulate NGF-mediated secretion.
    López-Benito S; Lillo C; Hernández-Hernández Á; Chao MV; Arévalo JC
    J Cell Sci; 2016 May; 129(9):1866-77. PubMed ID: 26966186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.
    Miguez A; García-Díaz Barriga G; Brito V; Straccia M; Giralt A; Ginés S; Canals JM; Alberch J
    Hum Mol Genet; 2015 Sep; 24(17):4958-70. PubMed ID: 26063761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery.
    Zuccato C; Liber D; Ramos C; Tarditi A; Rigamonti D; Tartari M; Valenza M; Cattaneo E
    Pharmacol Res; 2005 Aug; 52(2):133-9. PubMed ID: 15967378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF prevents NMDA-induced toxicity in models of Huntington's disease: the effects are genotype specific and adenosine A2A receptor is involved.
    Martire A; Pepponi R; Domenici MR; Ferrante A; Chiodi V; Popoli P
    J Neurochem; 2013 Apr; 125(2):225-35. PubMed ID: 23363456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease.
    Jin J; Peng Q; Hou Z; Jiang M; Wang X; Langseth AJ; Tao M; Barker PB; Mori S; Bergles DE; Ross CA; Detloff PJ; Zhang J; Duan W
    Hum Mol Genet; 2015 May; 24(9):2508-27. PubMed ID: 25609071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.